Attana has filed a new patent application with claims for methods for assessing the neutralising potential of antibodies in biological samples. The invention is applicable in both of Attana's business areas - Life Science and Diagnostics. Attana has filed a new patent application with several claims assessing the neutralising potential of antibodies or other biological entities in complex biological samples.

The invention can be applied within diagnostics with the purpose to better determine the immunity of individuals based on several parameters, such as kinetics and titres of immune responding agents. Additionally, it can also be applied in both pre-clinical and clinical drug development to obtain increased information on human immune response. The Attana patent application covers several aspects on assessing kinetics of an interaction between e.g., an antigen and an antibody as well as the combination with neutralizing titre.

The work has been performed in collaboration with Prof. Ian Nicholls and Dr. Per Nilsson at the Linnaeus University. Selected parts of the invention will be published in one or more scientific publications, which will be submitted in the near future.